Get Started

NRXP

NASD NRX Pharmaceuticals, Inc.
Nov 5, 2026 · 9:16 AM ET LAST TRADE Market Closed

$2.50 ↑ +0.01 (+0.40%) Trading Up from the previous close of $2.49

YTD change
-7.75%
vs 20-day SMA
-3.33%
vs 200-day SMA
-15.81%

Price ranges

Previous day
$2.30 $2.51
open $2.30 close $2.49
+$0.19 (+8.26%)
Today
$0.00 $0.00
$2.50
Past week
$2.11 $2.84
from $2.69 now $2.50
-$0.19 (-7.06%)
Past month
$2.11 $2.93
from $2.90 now $2.50
-$0.40 (-13.79%)
This year
$1.62 $5.06
from $2.71 now $2.50
-$0.21 (-7.75%)

Price & Performance

-0.55 (-18.09%) / 6M

$1.97$2.92$3.87$4.82May 5Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 99.0% away from all-time highs of $262.40
  • NRXP is down 8% since the beginning of the year
  • NRXP is down 6% over the past 12 months
  • NRXP is down 14% over the past 1 month
  • 27% of all NRXP investors are betting against NRXP

NRXP reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -6.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.44
Earnings momentum -106.2% Quarterly EPS growth
Quarterly change -106.2%

Valuation

P/E ratio N/A
Enterprise value $68.3M
Beta 3.00

Balance sheet & scale

IncomeN/A
Revenue$3.4M
Cash$26.7M
Debt$1.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $108.2M

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.